Description:
About Ibrucent 140 Mg
Each capsule of Ibrucent 140 mg contains Ibrutinib INN 140mg. Ibrutinib is a small-molecule inhibitor of BTK. Incepta Pharmaceuticals LTD is the manufacturer of Ibrucent 140mg.
Dosage:
Recommended dosage of Ibrucent 140 mg is one tablet orally four times daily, with or without food, until disease progression or unacceptable toxicity. It should be taken at the same time each day. Whole capsule should be swallowed with water and the capsule should not be chewed or crushed. Or, as directed by the registered physician.
Side Effects:
- Haemorrhage
- Infections
- Cytopenia
- Cardiac Arrhythmias
- Hypertension
- Second Primary Malignancies
- Tumour Lysis Syndrome
Storage:
Ibrucent 140 mg should be stored below 30°C in a dry and clean place, away from sunlight and out of the reach of children.
Reviews
There are no reviews yet.